Cosyntropin
Cosyntropin is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Stress and the Nervous System
Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis
Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?
Comparison of Intramuscular and Intravenous ACTH Stimulation Test in Normal Volunteers
Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction
Clinical Trials (8)
Stress and the Nervous System
Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis
Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?
Comparison of Intramuscular and Intravenous ACTH Stimulation Test in Normal Volunteers
Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction
Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture Headache
Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery
Study of the Approximate Entropy of Adrenocorticotropic Hormone and Cortisol Secretion in Patients With Head Injury
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8